Physician profile
Muhammad Kandel
NPI 1639520497
$75,645.61
in general payments reported to CMS, 2019-2025
8 companies · $1,542 in 2025
The $1,542 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $303 · 2021: $73K · 2022: $8.68 · 2023: $569 · 2024: $171 · 2025: $1,542.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,441 · Food and Beverage: $841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,441.13 |
| Food and Beverage | $841.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $73,000.00 | 2021 | |
| Medtronic, INC. | $1,552.98 | 2021-2025 | Cd Horizon Spinal System, Mazor X System, Unid_pass |
| Corelink, LLC | $466.22 | 2022-2023 | |
| Stryker Corporation | $354.73 | 2019-2024 | Duramatrix, Direct Inject, Adherus Autospray Et Dural Sealant |
| Depuy Synthes Sales INC. | $185.19 | 2023-2024 | Trumatch, Teligen |
| Integra Lifesciences Corporation | $41.21 | 2025 | Cusa Clarity, Codman Hakim, Codman Certas |
| Solventum Corporation | $35.46 | 2024 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
| Zavation Medical Products, LLC | $9.82 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Kandel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.